Clinical trial
Evaluation of 18F-Fluciclovine PET-MRI to Differentiate Tumor Progression From Post-treatment Changes in Pediatric High-grade Glioma (HGG)
NCT05553041 is registered in ClinicalTrials.gov with Children's Hospital of Philadelphia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of 18F-Fluciclovine PET-MRI to Differentiate Tumor Progression From Post-treatment Changes in Pediatric High-grade Glioma (HGG)
- Lead sponsor
- Children's Hospital of Philadelphia
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- August 7, 2024
- Completion date
- December 31, 2027
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diffuse glioma, glioma, glioma intracranial, glioma, malignant, high grade glioma